Matt Portch is a highly accomplished biopharmaceutical executive with more than 30 years of experience in market access, sales strategy, and commercial model innovation. With a strong background in building and leading account management organizations, Matt has helped shape how life sciences companies engage with today’s complex, value-driven healthcare marketplace.

Matt has held senior leadership roles at some of the industry’s most prominent companies, including Bristol-Myers Squibb, Pfizer, and Sunovion Pharmaceuticals. At Pfizer, he served as Vice President of Commercial Model Innovation, where he was responsible for redesigning the company’s sales and marketing model to align with the needs of evolving healthcare customers—including health systems, hospitals, and integrated delivery networks. Matt also founded and led Pfizer’s Key Account Management organization, positioning the team as a strategic partner to large-scale healthcare providers and systems.

His leadership track record includes roles such as National Account Director at BMS, Vice President of Market Access at Pfizer, and SVP of Sales and Market Access at Sunovion Pharmaceuticals. In each of these roles, Matt brought a forward-looking, enterprise mindset—expanding access, strengthening stakeholder engagement, and developing field strategies that advanced both product value and patient outcomes.

Currently, Matt serves as a consultant with WLH, where he partners with life sciences clients to build and refine Key Account Management capabilities, market access strategies, and B2B engagement models. He has developed a proven toolkit for teams to better meet the needs of organized customers and payers, and regularly advises commercial and portfolio teams on how to navigate the rapidly changing access landscape.

In addition to his consulting work, Matt is a Senior Advisor at Formulary Insights, a cutting-edge platform that delivers real-time, credible market access insights to pharmaceutical companies, investors, and healthcare innovators. Through this role, he contributes to advancing industry understanding of payer dynamics and specialty pharmacy strategies.

Matt is widely recognized for his strategic agility, deep institutional knowledge, and ability to bridge commercial innovation with practical execution. His global experience and collaborative leadership style make him a trusted voice in the future of pharmaceutical market access.

Matt received his BA in Business / Managerial Economics from Eastern Washington University. Throughout his career he obtained certifications in DiSC, Strategic Dialogue Skills, and Six Sigma Yellow Belt.